DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Reddy's launches in-house palbociclib (PRIMCYV(r)) to widen access to high-quality breast cancer drug13-01-2023
13-01-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Reddy''s to release Q3 FY 23 results on January 25th, 2023 Earnings call slated for January 25th @ 7:00 PM IST / 8:30 AM EST12-01-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation regarding resignation of Mr. Allan Oberman as an Independent Director06-01-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding participation at investor conferences06-01-2023
Revlimid: Claims against Dr Reddy's in US court dismissed
Revlimid is indicated in treatment of multiple myeloma29-12-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201529-12-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Closure of Trading Window
The trading window for dealing in securities of the Company will be closed from December 31, 2022, to January 27, 2023 (both days inclusive).27-12-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ending On December 31, 2022.
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Wednesday, January 25, 2023, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2022.27-12-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication- Loss of Share Certificates26-12-2022